MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹3.66 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.66 Cr | -65.52 | |
| Mar2024 | ₹11 Cr | -30.98 | |
| Mar2023 | ₹15 Cr | 11.78 | |
| Mar2022 | ₹14 Cr | 89.48 | |
| Mar2021 | ₹7.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,964.5 Cr | 0.3% | 8.9% | 8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.3% |
8.9% |
8.1% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses